Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. Issue 7 (July 2014)
- Record Type:
- Journal Article
- Title:
- Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. Issue 7 (July 2014)
- Main Title:
- Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma
- Authors:
- Mylam, Karen J.
El-Galaly, Tarec C.
Hutchings, Martin
Brown, Peter
Himmelstrup, Bodil
Gerke, Oke
Gillstrøm, Dorte
Sillesen, Ida B.
Munksgaard, Lars
Pedersen, Bjarne B.
Christiansen, Ilse
Jensen, Paw
Nielsen, Anne L.
Pedersen, Lars M. - Abstract:
- <abstract> <title>Abstract</title> <p>The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (<italic>p</italic> < 0.001), respectively. Two-year OS for patients with E-PET was 41%, 89% and 97% (<italic>p</italic> < 0.001) for positive, indeterminate and negative interpretation of PET/CT reports. Progression-free survival and OS did not differ significantly in patients with a negative and an indeterminate I-PET report. The use of well-defined reporting criteria, e.g. the Deauville five-point scale, is likely to reduce the number of scans perceived as indeterminate.</p> </abstract>
- Is Part Of:
- Leukemia & lymphoma. Volume 55:Issue 7(2014:Jul.)
- Journal:
- Leukemia & lymphoma
- Issue:
- Volume 55:Issue 7(2014:Jul.)
- Issue Display:
- Volume 55, Issue 7 (2014)
- Year:
- 2014
- Volume:
- 55
- Issue:
- 7
- Issue Sort Value:
- 2014-0055-0007-0000
- Page Start:
- 1563
- Page End:
- 1569
- Publication Date:
- 2014-07
- Subjects:
- Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419 - Journal URLs:
- http://informahealthcare.com ↗
- DOI:
- 10.3109/10428194.2013.850165 ↗
- Languages:
- English
- ISSNs:
- 1042-8194
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3662.xml